| Cat.No. | Name | Information |
|---|---|---|
| M11292 | FAPI-4 | Feiapi-4 is a fibroblast activating protein (FAP) inhibitor that can be used in cancer research. |
| M9609 | SP-13786 | SP-13786 (UAMC-1110) is a novel potent and selective inhibitor of fibroblast activation protein (fap), displaying low nanomolar inhibitory potency and high selectivity against the related dipeptidyl peptidases (dpps) dppiv, dpp9, dppii, and prolyl oligopeptidase (prep). |
| M52858 | 3BP-3940 | 3BP-3940 is a highly potent fibroblast activation protein (FAP)-targeting peptide for theranostics. |
| M41981 | NH2-UAMC1110 TFA | NH2-UAMC1110 TFA is a UAMC1110 derivative that can be used in the synthesis of FAPI-QS. |
| M41980 | FAP-IN-1 | FAP-IN-1 is a fibroblast activation protein (FAP) inhibitor with an IC50 value of 3.3 nM. |
| M41979 | FAPI-74 | FAPI-74 is a PET (positron emission tomography) tracer targeting the fibroblast activation protein (FAP). |
| M41978 | FAP-IN-2 TFA | FAP-IN-2 TFA is a 99mTc-labeled isonitrile-containing FAP inhibitor derivative that can be used for tumor imaging. |
| M41977 | FAP-IN-2 | FAP-IN-2 is a derivative of 99mTc-labeled isonitrile-containing fibroblast activation protein (FAPI) inhibitor, that can be used for tumor imaging. |
| M40766 | MP0317 | MP0317 is a CD40 agonist as well as a fibroblast activating protein alpha (FAP) modulator for studies related to solid tumors. |
| M24966 | Sibrotuzumab | Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC). |
| M11290 | Ac-Gly-BoroPro | Ac-gly-boropro is a selective FAP inhibitor with Ki value of 23 nM.*The compound is unstable in solutions, freshly prepared is recommended |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
